During the last session, Cardio Diagnostics Holdings Inc (NASDAQ:CDIO)’s traded shares were 1.08 million, with the beta value of the company hitting 4.57. At the end of the trading day, the stock’s price was $0.24, reflecting an intraday loss of -6.04% or -$0.02. The 52-week high for the CDIO share is $3.56, that puts it down -1383.33 from that peak though still a striking 20.83% gain since the share price plummeted to a 52-week low of $0.19. The company’s market capitalization is $9.88M, and the average intraday trading volume over the past 10 days was 7.88 million shares, and the average trade volume was 2.77 million shares over the past three months.
Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) trade information
Cardio Diagnostics Holdings Inc (CDIO) registered a -6.04% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.04% in intraday trading to $0.24, hitting a weekly high. The stock’s 5-day price performance is -20.66%, and it has moved by 12.02% in 30 days. Based on these gigs, the overall price performance for the year is -88.95%. The short interest in Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) is 1.68 million shares and it means that shorts have 0.7 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cardio Diagnostics Holdings Inc (CDIO) estimates and forecasts
Statistics show that Cardio Diagnostics Holdings Inc has outperformed its competitors in share price, compared to the industry in which it operates. Cardio Diagnostics Holdings Inc (CDIO) shares have gone down -65.85% during the last six months, with a year-to-date growth rate more than the industry average at 50.00% against 18.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 94.36% this quarter and then jump 70.00% in the quarter after that. In the rating firms’ projections, revenue will increase 245.64% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 25k as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 50k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 5.31k and 15.93k respectively. In this case, analysts expect current quarter sales to grow by 370.81% and then jump by 213.87% in the coming quarter.
While earnings are projected to return 45.45% in 2024.
CDIO Dividends
Cardio Diagnostics Holdings Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cardio Diagnostics Holdings Inc (NASDAQ:CDIO)’s Major holders
Cardio Diagnostics Holdings Inc insiders own 9.86% of total outstanding shares while institutional holders control 4.15%, with the float percentage being 4.60%.
